Oregon Drug Discovery Symposium

Oregon Drug Discovery Symposium 2026 is now accepting abstracts for poster presentations.

See the Abstract Submission dropdown section below for details.

Oregon Drug Discovery Symposium 2026

Connect with the drug discovery community!

Sanjay Malhotra

Welcome to the Oregon Drug Discovery Symposium (ODDS). This event offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate days of exciting talks and discussions, including a poster session. We look forward to welcoming you to OHSU for ODDS 2026.  

Sanjay V. Malhotra, Ph.D., Director, OHSU Center for Experimental Therapeutics 

Save the date: April 8-9, 2026

Knight Cancer Research Building
2720 S. Moody Ave.
Portland, OR 97201

A virtual option will be available.

Questions? 
Email CET@ohsu.edu

Information about speakers will be posted here.

You will receive an email from EventBrite containing your ticket and registration information. Please save this email for future reference and to show at registration. If you are on the waitlist or register to attend virtually, you will receive an email but will not receive a ticket. If you have questions about your registration, please email CET@ohsu.edu.

2026 Registration Rates

Academia / Non-profit $100
Industry $250
Virtual Attendance $25
Trainees / Students $50

Oregon Drug Discovery Symposium 2026 is now accepting abstracts for poster presentations.

ODDS Abstract Submission – Fill out form

The abstract submission deadline is February 15th, 2026. Participants must submit by the deadline to be considered for the poster competition. Poster presentations will not be available to virtual participants. If you are presenting a poster, you must also register for the conference. 

Abstract submission deadline may be extended based on availability.

General information: 

  • Poster size should be no larger than 48 inches x 48 inches (122 cm x 122 cm). A 36 in x 48 in poster (in landscape or portrait orientation) is a common size.
  • Abstracts are limited to 2500 characters, including spaces.
  • Please proofread your abstract carefully for spelling and data errors. Pay special attention to the author order and the presenting author designation

To discuss conference sponsorship or for sponsorship questions, please contact: CET@ohsu.edu

Sponsorship Tiers

Core Sponsor - $10,000
Premier sponsor benefits plus choice of 2 Add-On Opportunities from the list below.

Premier Sponsor — $5,000
6 sponsorships at this level

  • Preferred 6’ exhibitor table located near the main session hall and refreshment area.
  • Entry for two (2) representatives.
  • Company logo and 100-word profile in the event program and on the symposium website.
  • Recognition in opening and closing remarks.
  • Acknowledgment on event signage and welcome slides.

Poster Sponsor — $3,000
10 sponsorships at this level

  • Poster in industry poster space.
  • Entry for two (2) representatives.
  • Company logo listed in the event program and website.
  • Recognition in opening remarks.

Non-Exhibiting Industry Participant — $250

  • Entry for one (1) representative (no exhibit table).
  • Company name listed in the event program.

Add-On Opportunities
For enhanced visibility

  • Breakfast Sponsor – $750
      Logo signage at refreshment stations and acknowledgment during remarks.
     
  • Coffee Break Sponsor – $500
      Logo signage at refreshment stations and acknowledgment during remarks.
     
  • Lunch Sponsor – $1,000
      Logo signage at refreshment stations and acknowledgment during remarks.
     
  • Reception Sponsor – $750
      Logo signage at refreshment stations and acknowledgment during remarks.
     
  • Dinner Sponsor – $2,000
      Logo signage at refreshment stations and acknowledgment during remarks.
     
  • Trainee Travel Support – $1,500
      Recognition in program and signage for supporting trainee attendance.

Venue

Knight Cancer Research Building
Oregon Health & Science University
2720 S.W. Moody Ave.
Portland, OR 97201

Accommodations

Downtown Portland has many hotels and lodging options conveniently connected by light rail, Portland street car, and bus lines.

The recommended hotel for the conference is the Hyatt House Portland Downtown. The hotel is conveniently located .3 miles from the venue, within easy walking distance.  

Hyatt House Portland Downtown
2080 SW River Drive
Portland, OR 97201
503-241-2775
Map

Additional lodging options include:

Local Transportation

The conference venue is just south of downtown Portland, Oregon, and easily accessible by the Portland Streetcar and MAX light rail.  This makes most downtown Portland hotels a convenient choice for conference accommodations. 

Parking

Limited parking will be available at the Schnitzer Parking Lot, located next to the Knight Cancer Research building. Kiosks available to pay for parking with a credit card.

Schnitzer lot address: 2600 S. Moody Avenue, Portland, OR  97201

Sanjay Malhotra

Sanjay Malhotra, Ph.D.
Professor of Cell, Developmental and Cancer Biology, OHSU School of Medicine
Endowed Chair, Cancer Research, Cell, Developmental and Cancer Biology, OHSU School of Medicine
Director, OHSU Center for Experimental Therapeutics

Shivaani Kummar

Shivaani Kummar, M.D., FACP
Chief Executive, OHSU Knight Cancer Institute
Margaret and Lester DeArmond University Chair of Molecular Oncology, Medicine, Division of Hematology/Medical Oncology, OHSU School of Medicine
Co-Director, Center for Experimental Therapeutics, OHSU Knight Cancer Institute
 

Annah Rolig

Annah Rolig, Ph.D.
Senior Scientist, Center for Experimental Therapeutics, OHSU

Denise Hopkins

Denise Hopkins
Program Administrator, Center for Experimental Therapeutics, OHSU 

Sponsors

Interested in being a sponsor or media partner for ODDS? Email CET@ohsu.edu.

Archive

Oregon Drug Discovery Symposium participants, 2025
On April 9, 2025, the OHSU Center for Experimental Therapeutics (CET) hosted the inaugural Oregon Drug Discovery Symposium (ODDS) at the Knight Cancer Institute. The symposium drew over 350 attendees from across the country, including researchers, start-ups, and investors.